PERK-mediated upregulation of vascular endothelial growth factor (VEGF), fibroblast growth factor-2 (FGF2), and interleukin-6 (IL-6), coupled with the downregulation of anti-angiogenic cytokines, markedly promotes tumor growth [292] (Table 4). Here, IL6 is linked to neoplasm.